Helena Posteri

发表

A new glycociamidine ring precursor: syntheses of (Z)-hymenialdisine, (Z)-2-debromohymenialdisine, and (+/-)-endo-2-debromohymenialdisine.

D. Borghi, M. Varasi, G. Papeo, 2005, Organic letters.

Poly(ADP-ribose) polymerase inhibition in cancer therapy: are we close to maturity?

A. Montagnoli, P. Orsini, B. Forte, 2009, Expert opinion on therapeutic patents.

4,5-Dihydro-1H-pyrazolo[4,3-h]quinazolines as potent and selective Polo-like kinase 1 (PLK1) inhibitors.

F. Fiorentini, M. Brasca, F. Roletto, 2010, Bioorganic & medicinal chemistry letters.

NMS-P937, a 4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline derivative as potent and selective Polo-like kinase 1 inhibitor.

F. Fiorentini, M. Brasca, E. Pesenti, 2011, Bioorganic & Medicinal Chemistry Letters.

Mimics of ganglioside GM1 as cholera toxin ligands: replacement of the GalNAc residue.

D. Potenza, A. Bernardi, D. Arosio, 2003, Organic & biomolecular chemistry.

434 POSTER Antitumoral activity of pyrazoloquinazoline derivatives as potent oral Plk-1 specific inhibitors

M. Brasca, E. Pesenti, M. Rocchetti, 2008 .

Identification of 4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline derivatives as a new class of orally and selective Polo-like kinase 1 inhibitors.

D. Ballinari, V. Croci, D. Volpi, 2010, Journal of medicinal chemistry.

Stereoselective synthesis of (Z)-axino- and (Z)-debromoaxinohydantoin

D. Borghi, N. Mongelli, F. Quartieri, 2009 .

Synthesis and SAR of new pyrazolo[4,3-h]quinazoline-3-carboxamide derivatives as potent and selective MPS1 kinase inhibitors.

Riccardo Colombo, M. Angiolini, Daniele Donati, 2011, Bioorganic & medicinal chemistry letters.

Synthesis, Conformational Studies and Mannosidase Stability of a Mimic of 1,2‐Mannobioside

G. Marcou, D. Potenza, A. Bernardi, 2004 .

Nicotinoyl azide (NCA)-mediated Mitsunobu reaction: An expedient one-pot transformation of alcohols into azides

M. Varasi, P. Vianello, G. Papeo, 2004 .

Discovery of 2-[1-(4,4-Difluorocyclohexyl)piperidin-4-yl]-6-fluoro-3-oxo-2,3-dihydro-1H-isoindole-4-carboxamide (NMS-P118): A Potent, Orally Available, and Highly Selective PARP-1 Inhibitor for Cancer Therapy.

Antonella Isacchi, Enrico Pesenti, Fabio Zuccotto, 2015, Journal of medicinal chemistry.

Discovery of Stereospecific PARP-1 Inhibitor Isoindolinone NMS-P515.

A. Isacchi, E. Casale, E. Felder, 2019, ACS medicinal chemistry letters.